Lecture Material
Ogden
Lecture Notes:
Molecular Genetics and Control Friday January 18
Movie Links
http://vcell.ndsu.nodak.edu/~christjo/vcell/animationSite/lacOperon/movie.htm - lac operon
http://www.learner.org/channel/courses/biology/units/gmo/images.html - recombinant DNA and transgenic animals
Alteration of Cell Information Weds 1/23
Lecture 3 Genetically Engineering Organisms Fri 1/25
Lecture 4 Monday 1/28 and Weds 1/30
http://highered.mcgraw-hill.com/sites/0072556781/student_view0/chapter11/animation_quiz_5.html
Lecture 5 Genetic Instability 2/1
Cell Growth Summary 2/4
http://azilliad.library.arizona.edu/illiad/pdf/451167.pdf - Text book chapter on genetically modified organisms
Riley
Animal cells for pharmaceutical production
Topic Reading assn
1 Cell and tissue culture Palsson Chp 9, 10
2 Pathways and biosynthesis Reading 2
3 Control and modeling of metabolism Reading 3 Glucose model
4 Stoichiometry and production kinetics Reading 4
5 Pharmaceutical production Reading 5
6 Immune system function Reading 6; Palsson, Chp 18.3
7 Optimize cells (Cell line development and screening) Reading 7; Palsson, Chp 8
8 Optimize environment (Bioreactors)
9 Pharmaceutical product dosing and storage Reading 9
Spring break
11 Overview and introduction to TE approaches
12 Tissue organization and dynamics Palsson, Chp 3, 4
13 Interacting cell fate processes Palsson, Chp 18
14 Stem cells and differentiation Palsson, Chp 5
15 Time constants and analyses (transport, kinetics) Palsson, Chp 12
16 Bioreactor design and scale up for tissue engineering Palsson, Chp 13
17 Cell separation and isolation Palsson, Chp 14
18 Biomaterials for tissue engineering Palsson, Chp 15, 16
19 Cellular biomechanics Biomechanics reading
21 Case study I: connective tissue (a) Normal structure Connective tiss reading
22 Case study I: connective tissue (b) Functional requirements
23 Case study I: connective tissue (c) Design of TE replacement
24 Case study II: cardiovascular tissue (a) Normal structure BV reading
25 Case study II: cardiovascular tissue (b) Functional requirements
26 Case study II: cardiovascular tissue (c) Design of TE replacements
27 Preservation of cells and tissues Palsson, Ch 10.6, 19
28 Clinical implementation Palsson, Chp 17, 19